Eurosurv. Epidemiological analysis of confirmed mpox cases, Burundi, 3 July to 9 September 2024

[tetano]

• Alexis Nizigiyimana[SUP]1,2[/SUP] , Francois Ndikumwenayo[SUP]2,3[/SUP] , Sarah Houben[SUP]4[/SUP] , Martin Manirakiza[SUP]3,5[/SUP] , Monique van Lettow[SUP]6,7[/SUP] , Laurens Liesenborghs[SUP]4[/SUP] , Placide Mbala-Kingebeni[SUP]8,9[/SUP] , Anne W Rimoin[SUP]10[/SUP] , Isaac I Bogoch[SUP]11[/SUP] , Jason Kindrachuk[SUP]2,12,13[/SUP]

​We analysed mpox cases in Burundi from July to September 2024, following the introduction of Clade Ib virus. Of 607 samples from the whole population of suspected cases, 154 were PCR-positive, of whom 85 were children under 15 years, with a higher proportion of female children testing positive. Geographical analysis demonstrates case concentration in Bujumbura Mairie (91/154). Age- and sex-specific interventions, as well as community engagement, are important for outbreak containment, as are targeted public health strategies in Burundi.


https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2024.29.42.2400647

 

[sharon sanders]

snip from above....

Clade Ib has undergone rapid regional expansion that has included introduction to North Kivu, DRC [2], as well as dissemination to neighbouring countries in East Africa. Case totals were highest in Burundi with 987 confirmed cases as of 13 October 2024.​